Informa
Register Now

Innovate to Elevate Advancing

See you in 2025

#

BIOPHARMA CONCLAVE 2024

The 6th Edition of Biopharma Conclave is scheduled for 3rd-4th September 2024 in Hotel Sahara Star, Mumbai and will be a grand platform for discussing the trends, challenges, solutions, and innovation in the industry. For the first time, this preview comes in two extensive product-based tracks -: Biosimilars & Biologics, And Cell & Gene.

What’s Happening this Year

30+ hours of engaging content across 2 days

45+ Speakers

2 Conference tracks

5 hours of Networking session

300+ Biopharma Industry Professionals Under one Roof

Biopharma Leader's Roundtable
(Invite Only)

Technology Showcase

Regulatory Update

Key Focus Areas

#

Biosimilars & Biologics

The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.

#

Cell and Gene Therapy

The track will emphasize on CGT: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.

We have a proven track record of success

50+

Speakers

25+

Exhibitors

4+

Focused tracks

300

Attendees

Our Speakers

Speaker

Dhananjay Patankar

Independent Biopharmaceutical Professional

Speaker

Tathagata Dutta

CTO and President

Jodas Expoim

Speaker

Dr. Shubhadeep Sinha

SVP, Development

Hetero

Speaker

Narendra Chirmule

CEO, Director and Co-Founder

SymphonyTech Biologics

Speaker

Dr. Arani Chatterjee

Joint President

Cadila Pharma

Speaker

Ashok Kumar

President, Centre for Research & Development

IPCA Laboratories

Speaker

Dhananjay Patankar

Independent Biopharmaceutical Professional

Speaker

Dr. Lalit Raute

Associate Director, Regional Therapeutic Area Market Access & Pricing Lead – Oncology , Southeast Asia and India

Johnson and Johnson Innovative Medicine
Malaysia

Speaker

Rahul Purwar

Chief Executive Officer

ImmunoACT

Speaker

Rakesh Mishra

Director

Tata Institute for Genetics and Society

Speaker

Prof. Samir Kulkarni

Head, Department of Biological Sciences and Technology

ICT, Mumbai

Speaker

Dr. Shubhadeep Sinha

SVP, Development

Hetero

Speaker

Sanjeev Gupta

Senior Vice President- Advanced Biotech Lab

IPCA Laboratories

Speaker

Yoganathan Rajendran

Head-Regulatory affairs & Quality Assurance (CAR-T / Cell and Gene therapy / ATMP)

Immuneel Therapeutics Private Limited

Speaker

Mukesh Kumar

Ex-Senior Vice President & Head - Clinical R&D

Cipla

Speaker

Sourabh Fulmali

Global Medical Director

GSK

Speaker

Ashok Kumar Patra

Director, Biologics Development

Imgenex India

Speaker

Ashutosh Kumar

Professor

IIT, Bombay

Speaker

Pramod Wangikar

Chair Professor for Green Chemistry and Industrial Biotechnology, Department of Chemical Engineering

IIT, Bombay

Speaker

Mannan Khambati

Assistant Vice President, Biotech manufacturing

BSV

Speaker

Prasad Krishnamurthy

Co-Founder

Biocognate

Speaker

Swati Chitrangi

Head of Production

Advancells

Speaker

Dinesh Kundu

Director & Founder

East Ocyon Bio

Speaker

Ravishankar Kasturi

Head of Operations

Enzene Biosciences

Speaker

Somnath Basu

Team Leader of reviewers of "drugs"

National Regulatory Authority (NRA) for "drugs"

Speaker

Shirish Arya

Co-Founder & Director - Corporate Strategy & Business Development

ImmunoACT

Speaker

Maloy Ghosh

CSO

Zumutor Biologics

Speaker

Sandeep Majumdar

Associate Executive Vice President- Biologics Operations

Intas

Speaker

Albeena Nisar

Senior Lead R&D & CMC

ACTREC

Speaker

BN Manohar

MD & CEO

Stempeutics Research Pvt. Ltd.

Speaker

Narsimha Nedunuri

Managing Director & CEO

Clonz Biotech Pvt Ltd

Speaker

Gaurav Narula

Project Lead: CAR T & Cell Therapy Center

Tata Memorial Center, Homi Bhabha National Institute, Mumbai

Speaker

Ritwick Tandon

Senior Director & LSSMBB, COE

Biocon

#

Aruna Kumar Chelluboyina

Assitant Professor

Mahindra University, Hyderabad

#

Susheelendra Vaidya

FAS-Technical Expert, APAC- Bioanalytics

Sartorius India

#

Alok Mehrotra

Chief Quality Officer

Syngene International

#

Yu Chen

Managing Director

Bio-Link Biotech, Hong Kong

#

Satyen Sanghavi

Founder & CSO

Regrow Biosciences

#

Arindam Saha

Project Group Leader

Biocon Biologics

#

Dr. Soumya Ranjan Satapathy

Senior Technical Manager (India)

DFE Pharma

#

Sudarshan Jain

Secreatary General

Indian Pharmaceutical Alliance

#

Dr. Jezamine Lim

CEO & Co-Founder

Cell Biopeutics Resources, Malaysia

#

Dr. Shridhar Narayanan

Senior Technical Advisor

Indian Pharmaceutical Association

#

Rahul Jias

Chief Operating Officer

Biosimilar Sciences India

#

Goutam Bhattacharya

Chief Executive Officer

Life Sciences Sector Skill Development Council

#

Fei Chuin Taylor-Lew

Cell Analysis Sales Manager- South Asia Pacific & India

Agilent Technologies

Testimonials

What People Say?

Interactions have been very good, exchange of information in terms of biosimilars, vaccines or even the cell & gene therapy is very new in the market. There is a lot of learning from both ends. The footfall for this event in the last two days have been phenomenal and more than expected.

Vishal Jaiman
Director – Business Development (India), Marken

Biopharma Conclave was very good, I think there are a lot more players in the market with lot more presenting this year.It’s an interesting mix of all the topics they have put together as the Biopharma industry is moving further into commercialization. This is a good platform for a lot of us to connect and present our views.

Gopal Rao
GM- Global BD and Licensing, Lupin Limited (Biotech Division)

So far it has been a wonderful experience and I was able to interact as well as meet many key personalities from India and abroad. We have expertise industry research in Biosimilars, Biologics, Vaccines and Gene therapy hence it has been a wonderful experience to learn a lot of advance techniques and development happening in this space.

Ramgopal Rao
Academic Manger, Biocon Academy

My experience at the Biopharma Conclave was great. It was good to hear from so many experts in the field of biopharma. The quality of the speakers is top notch, and it was great to hear from regulators and industry experts.

Dr. Sarah McMullen
Country Director, US FDA

This is the first day but there were so many interesting topics withvery interesting speakers. It was a networking event and informative session with lots of people.

Yaron R. Silberberg
PHD. Chief Scientist, Cellist Solution Center

I was very glad to know that there were ample safety protocols followed whilst hosting a show post Covid. There was also a self-declaration form which each of the participants had to sign. There was a thermal screening at the entrance. In terms of the discussion the dignities who came there were all very well recognized and knowledgeable. It was great to learn from each other and a great platform as well.

Divya Bijlwan
Senior Vice President- Business development, Aurobindo Pharma Ltd.

It’s a very nice gathering and we have people come here from various streams that is Vaccines, Biosimilars and Gene therapy.

Alston Fernandes
Head Technical, JNC Corporation

Our Partners

Gold Partner

#

Silver Partner

#
#

Associate Partner

#

Exhibit Partner

#
#
#
#
#
#
#
#
#
#
#

Knowledge Partners

#

Media Partners

#
#
#
#
#